Circulation on the Run

This week, please join Chair Roger Blumenthal and author Gregg Fonarow as they discuss the recently published "2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia" along with an accompanying commentary "The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise—But More Complicated—Framework for Atherosclerotic Cardiovascular Disease Prevention and Treatment."
For the episode transcript, visit:
https://www.ahajournals.org/do/10.1161/podcast.20260427.104601

This week, please join author Alexander "Sasha" Opotowsky as he discusses the article "The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260420.342132

This week, please join author Edouard L. Fu and Associate Editor Dhruv Kazi as they discuss the article "Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation."
For the episode transcript, visit: 
https://www.ahajournals.org/do/10.1161/podcast.20260413.101706

This week, please join author Rik Pauwels as he discusses the article "Wearable-Derived Training Load and Coronary Atherosclerosis in Middle-Aged and Older Athletes and Physically Active Controls: A New Perspective From the Master@Heart Study."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260406.965700

This week, please join authors Charles Khouri and Clément Jambon-Barbara as well as Associate Editor Kelly Chin as they discuss the article "Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design."
For the episode transcript, visit:  https://www.ahajournals.org/do/10.1161/podcast.20260330.77255